Improvement of dry-weight in dialysis patients using bioelectrical impedance analysis

Improvement of dry-weight in dialysis patients using bioelectrical impedance analysis - Dry-weight determination using BIA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36049

Enrollment

160

Registered

2012-02-01

Start date

2012-07-09

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid overload dry-weight

Interventions

Measurement of the body composition using Bio-electrical Impendance Analysis

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients must have CKD stage 5 and treatment with hemodialysis or peritoneal dialysis

Exclusion criteria

Exclusion criteria: Heart failure Expected to receive a living donor transplant within 6 months Life expectancy less than 6 months Contraindications for the use of BIA measurements (due to expected measurement errors)

Design outcomes

Primary

Measure	Time frame
Blood pressure	—

Secondary

Measure	Time frame
Number of hospital admissions due to fluid overload Number of additional dialysis sessions due to fluid overload Number of intradialytic hypotension episodes and/or the number hypotension-associated dialysis symptoms Number of antihypertensive drugs Serum levels of NT-proBNP, albumin and CRP Cardiovascular related morbidity and mortality Development of anuria (200 ml/day)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)